Methylglucamine; Meglumin; Methylglucamin MedChemExpress (MCE)

Product Name	N-Methyl-D-glucamine
Synonyms	Meglumin Meglumine Methylglucamin Methylglucamine n-methylglucamine N-Methyl-D-glucamine D(-)-N-METHYLGLUCAMINE Synonyms Meglumin Meglumine Methylglucamin Methylglucamine n-methylglucamine N-Methyl-D-glucamine D(-)-N-METHYLGLUCAMINE 1-Deoxy-1-(methylamino)hexitol 1-deoxy-1-(methylamino)hexitol 1-deoxy-1-methylamino-D-glucitol 1-deoxy-1-(methylamino)-d-glucito 1-deoxy-1-(methylammonio)-D-allitol 1-deoxy-1-(methylammonio)-D-glucitol 1-deoxy-1-(methylammonio)-D-altritol D-GLUCITOL, 1-DEOXY-1-(METHYLAMINO)- 1-deoxy-1-(methylammonio)-D-mannitol Glucitol, 1-deoxy-1-(methylamino)-, D-
CAS	6284-40-8
EINECS	228-506-9
Chemical Formula	C7H17NO5
Molecular Weight	195.21
inchi	InChI=1/C7H17NO5/c1-8-2-4(10)6(12)7(13)5(11)3-9/h4-13H,2-3H2,1H3/p+1/t4-,5-,6+,7-/m1/s1
Package	10 mM * 1 mL;500 mg
Price	Email to quote
Descriptions	Meglumine Meglumine MedChemExpress (MCE) HY-B0342 6284-40-8 Methylglucamine Descriptions Meglumine Meglumine MedChemExpress (MCE) HY-B0342 6284-40-8 Methylglucamine Meglumin Methylglucamin 98.0% Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year Room temperature in continental US may vary elsewhere. Meglumine (Methylglucamine) is an orally active amino sugar derived from sorbitol. Meglumine has anti-inflammatory and antitumor activity. Meglumine is often used as an excipient in active molecules and with iodinated compounds in contrast agents such as meglumine and meglumine iodide. Meglumine (40 or 80 mM, 24 h 50 mM, 24 h) dose-dependently reduces the levels of inflammatory factors in THP-1 human myeloid cells and RAW264.7 mouse macrophage cells (Elisa assay)[2]. Meglumine (0-300 mM, 60 min) dose-dependently increases SNARK expression levels in C2C12 mouse myoblasts[4]. Meglumine (25 or 50 mM 37.5 mM, taken orally dissolved in water) reduces levels of inflammatory factors and inhibits skin cancer tumor growth in rats and mice[2]. Meglumine (18 mM, oral gavage) improves muscle function, limits metabolic syndrome, and reduces diabetic complications in type 2 diabetic mice[4]. \| \| \| \| \| \| \| \| \| \| [1]. de Souza ALR, et al. Meglumine-based supra-amphiphile self-assembled in water as a skin drug delivery system: Influence of unfrozen bound water in the system bioadhesiveness. Colloids Surf B Biointerfaces. 2019 Dec 1 184:110523. [Content Brief] [2]. Manley K, et al. Preclinical study of the long-range safety and anti-inflammatory effects of high-dose oral meglumine. J Cell Biochem. 2019 Jul 120(7):12051-12062. [Content Brief] [3]. Guo R Y, et al. Meglumine promoted one-pot, four-component synthesis of pyranopyrazole derivatives. Tetrahedron, 2013, 69(47): 9931-9938. [4]. Bravo-Nuevo A, et al. Meglumine exerts protective effects against features of metabolic syndrome and type II diabetes. PLoS One. 2014 Feb 27 9(2):e90031. [Content Brief]
Supplier Website	https://www.medchemexpress.com/meglumine.html
Last Update	2025-05-21 16:50:25

MedChemExpress (MCE) also provides

Thalidomide-4-O-C2-NH2

Category: Signaling Pathways
CAS: 2341840-99-9
Last Update: 2025-05-21 16:50:25

PPARα-MO-1

Category: Signaling Pathways
CAS: 810677-36-2
Last Update: 2025-05-21 16:50:25

Netupitant N-oxide

Category: Signaling Pathways
CAS: 910808-11-6
Last Update: 2025-05-21 16:50:25

MK-0812

Category: Signaling Pathways
CAS: 624733-88-6
Last Update: 2025-05-21 16:50:25

TS-011

Category: Signaling Pathways
CAS: 339071-18-0
Last Update: 2025-05-21 16:50:25

SCH 530348 sulfate

Category: Signaling Pathways
CAS: 705260-08-8
Last Update: 2025-05-21 16:50:25

BAG 956

Category: Signaling Pathways
CAS: 853910-02-8
Last Update: 2025-05-21 16:50:25

YM758

Category: Signaling Pathways
CAS: 312752-85-5
Last Update: 2025-05-21 16:50:25


Supplier Name	MedChemExpress (MCE)
Contact	sales
Tel	609-228-6898
Mobile	609-228-6898
QQ
Email	sales@medchemexpress.com; tech@medchemexpress.com
Website	https://www.medchemexpress.com/
Wechat

Request for quotation

Supplier Contact